Commentary: A New Year -- And A Renewal Of Dedication To Our Readers

With this issue, The Scientist steps forward into its fourth year of publication as the trade newspaper for the science professional. In celebrating this milestone, I can say with confidence that The Scientist has indeed arrived and is here to stay. Following its startup in October 1986, our young paper - like most fledgling publishing ventures - suffered its share of uncertainties. The solid gains it has posted in subscriptions and advertising since then - particularly during the past six mon

Written byEugene Garfield
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

With this issue, The Scientist steps forward into its fourth year of publication as the trade newspaper for the science professional. In celebrating this milestone, I can say with confidence that The Scientist has indeed arrived and is here to stay.

Following its startup in October 1986, our young paper - like most fledgling publishing ventures - suffered its share of uncertainties. The solid gains it has posted in subscriptions and advertising since then - particularly during the past six months - have thus been especially gratifying. Its progress attests, I believe, to the qualities that distinguish it from the other fine publications available to the science community.

Chief among these qualities is The Scientist's dedication to a broad cross section of professionals, including bench scientists, teachers, managers, and policymakers. The Scientist is not dedicated to tracking a specific discipline or subdiscipline; nor is it a vehicle for publishing original ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies